This topic contains a solution. Click here to go to the answer

Author Question: A patient is experiencing changes in heart rate and pupillary response to light. What division of ... (Read 31 times)

abern

  • Hero Member
  • *****
  • Posts: 533
A patient is experiencing changes in heart rate and pupillary response to light. What division of the nervous system is responsible for these changes?
 
  a. Central nervous system
  b. Somatic neurons
  c. Sensory neurons
  d. Autonomic nervous system

Question 2

You are treating an asthmatic who also happens to be taking propranolol (a  blocker) for a history of cardiac arrhythmias. What type of effect would you expect albuterol to have on this patient?
 
  a. Antagonistic effect
  b. Synergistic effect
  c. Little or no effect
  d. Additive effect



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

ANS: D

Answer to Question 2

ANS: C




abern

  • Member
  • Posts: 533
Reply 2 on: Jul 16, 2018
Excellent


anyusername12131

  • Member
  • Posts: 327
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library